Gara pubblica Aperta

Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tacrolimus (ATC-Code nach WHO: L04AD02)

In inglese: Conclusion of non-exclusive pharmaceutical discount agreements pursuant to § 130a para. 8 SGB V by way of an open-house model for the active substance tacrolimus (WHO ATC code: L04AD02)

Vedi il bando completo e i documenti: inizia la prova gratuita

14 giorni di prova gratuita. Nessuna carta richiesta.

Acquirente
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
Paese
Germania
Scadenza
31 ott 2026oggi
Settore
Sanità e medicina
Codice CPV
33600000 Prodotti farmaceutici
Pubblicato
29 ago 2025

La descrizione completa, i documenti, i contatti dell’acquirente e il link al portale ufficiale sono disponibili con la prova gratuita.

Altre gare in Germania

Gare aperte simili

  1. Open-house discount agreements 2026-11 - Dorzolamide ATR (EDO)
    Techniker Krankenkasse Scadenza: 31 ott 2026
  2. Open House Original Discount Contracts 2025-08 - Roxadustat
    Techniker Krankenkasse Scadenza: 31 ott 2026
  3. Open House Discount Contracts 2025-14 - Guanfacine (RET, strengths: 1-4 mg)
    Techniker Krankenkasse HEK - Hanseatische Krankenkasse Handelskrankenkasse (hkk) Scadenza: 31 ott 2026
  4. Open House Biologics Discount Contracts 2025-24 - Ranibizumab
    Techniker Krankenkasse Handelskrankenkasse (hkk) Scadenza: 31 ott 2026
  5. Open House Biologics Discount Contracts 2025-27 - Tocilizumab
    Techniker Krankenkasse HEK - Hanseatische Krankenkasse Handelskrankenkasse (hkk) Kaufmännische Krankenkasse (KKH) Scadenza: 31 ott 2026
  6. Conclusion of a non-exclusive pharmaceutical discount agreement pursuant to § 130a para. 8 SGB V by way of an open-house model for the active substance certolizumab pegol (WHO ATC code: L04AB05)
    AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen Scadenza: 31 ott 2026
  7. Conclusion of non-exclusive pharmaceutical discount agreements pursuant to § 130a para. 8 SGB V by way of an open-house model for the active substance glyceryl trinitrate (WHO ATC code: C05AE01)
    AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen Scadenza: 31 ott 2026
  8. Open-House Biologics Discount Agreements 2024-11 - Hepatitis B Immunoglobulin (ATC code J06BB04)
    Techniker Krankenkasse HEK - Hanseatische Krankenkasse Handelskrankenkasse (hkk) Scadenza: 31 ott 2026